Darbepoetin alfa Completed Phase 4 Trials for Neoplasm / Anemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00117039A Study to Evaluate the Effectiveness of AranespĀ® for Cancer Patients With Anemia